RESUMO
AIM: To study a relationship between main renal and intraparenchymal renal arterial resistance indices (RIs) measured by Doppler ultrasonography and clinical and laboratory parameters and to determine their prognostic value in estimating the progression of chronic kidney disease (CKD). SUBJECTS AND METHODS: The investigation enrolled 53 CKD patients divided into groups: glomerular and interstitial diseases. Glomerular filtration rate (GFR) calculated using the CKD-EPI formula, proteinuria (PU) severity, kidney sizes, renal parenchyma thickness, parenchyma/collecting index, and main and intrarenal vessel RIs were determined at the first hospitalization. The mean follow-up was 14 ± 2.64 months. The rate of GFR decline was estimated at the rehospitalization. RESULTS: Main renal and intrarenal vessel RIs depend on patient age and pulse pressure. The RIs are associated with GFR and PU in the group of glomerular diseases and with kidney sizes and structure in that of interstitial diseases. The interlobar arterial RI is the most sensitive predictor for worsening renal function with a threshold of 0.65, which is comparable to the prognostic value of PU. CONCLUSION: The main renal and intrarenal vessel RIs may be considered as a predictor for worsening renal function.
Assuntos
Artéria Renal/fisiopatologia , Insuficiência Renal Crônica/fisiopatologia , Resistência Vascular/fisiologia , Adulto , Progressão da Doença , Feminino , Taxa de Filtração Glomerular , Humanos , Rim/diagnóstico por imagem , Rim/fisiopatologia , Masculino , Artéria Renal/diagnóstico por imagem , Insuficiência Renal Crônica/diagnóstico , Estudos Retrospectivos , Ultrassonografia DopplerRESUMO
AIM: To investigate alterations of the complement system in patients with catastrophic antiphospholipid syndrome (CAPS). SUBJECTS AND METHODS: Four patients (2 men aged 23 and 40 years and 2 women aged 39 and 58 years) diagnosed as having CAPS, including 3 patients with systemic lupus erythematosus and secondary antiphospholipid syndrome (APS) and 1 patient with primary APS, were examined. The activity of the complement components C1-C5 and total hemolytic activity were determined in all the patients at the moment of an acute episode and in 1 patient after treatment. RESULTS: The activity of the studied complement components and total hemolytic complement activity proved to be significantly decreased in all the patients. That of complement components recovered after treatment using fresh frozen plasma. The possibility and mechanisms of complement system activation in the patients with CAPS are discussed. CONCLUSION: The preliminary results obtained by the examination of few cases may lead to the conclusion that the complement system may be involved in the development of CAPS.
Assuntos
Síndrome Antifosfolipídica/sangue , Proteínas do Sistema Complemento/biossíntese , Lúpus Eritematoso Sistêmico/sangue , Adulto , Síndrome Antifosfolipídica/etiologia , Síndrome Antifosfolipídica/terapia , Doença Catastrófica , Proteínas do Sistema Complemento/metabolismo , Feminino , Humanos , Lúpus Eritematoso Sistêmico/complicações , Masculino , Pessoa de Meia-Idade , Plasma , Troca Plasmática/métodos , Resultado do Tratamento , Adulto JovemAssuntos
Aspergilose/etiologia , Infecções por Citomegalovirus/etiologia , Imunossupressores/efeitos adversos , Pneumopatias Fúngicas/etiologia , Síndrome Nefrótica/tratamento farmacológico , Infecções Oportunistas/etiologia , Adulto , Anticorpos Antifúngicos/análise , Anticorpos Antivirais/análise , Antifúngicos/uso terapêutico , Antivirais/uso terapêutico , Aspergilose/tratamento farmacológico , Aspergilose/imunologia , Aspergillus/imunologia , Citomegalovirus/genética , Citomegalovirus/imunologia , Infecções por Citomegalovirus/tratamento farmacológico , Infecções por Citomegalovirus/imunologia , DNA Viral/análise , Quimioterapia Combinada , Seguimentos , Humanos , Tolerância Imunológica/efeitos dos fármacos , Pneumopatias Fúngicas/tratamento farmacológico , Pneumopatias Fúngicas/imunologia , Masculino , Síndrome Nefrótica/complicações , Síndrome Nefrótica/imunologia , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/imunologiaAssuntos
Transtornos da Coagulação Sanguínea/etiologia , Nefrite Lúpica/complicações , Adolescente , Adulto , Transtornos da Coagulação Sanguínea/sangue , Testes de Coagulação Sanguínea , Transtornos Plaquetários/sangue , Transtornos Plaquetários/etiologia , Coagulação Intravascular Disseminada/sangue , Coagulação Intravascular Disseminada/etiologia , Feminino , Hemorragia/sangue , Hemorragia/etiologia , Humanos , Nefrite Lúpica/sangue , Masculino , Pessoa de Meia-Idade , Síndrome Nefrótica/sangue , Síndrome Nefrótica/complicações , Proteinúria/sangue , Proteinúria/complicaçõesRESUMO
Out of 432 patients placed on the treatment with hemodialysis (HD) for terminal renal failure (TRF) at the All-Union Nephrologic Center from January 1, 1978 to December 31, 1987, 17 patients manifested partial recovery of renal function, which enabled dialysis treatment to be discontinued for a time. Among the 17 patients with noticeable improvement of renal function, 8 presented with lupoid rapid-progressing glomerulonephritis (RPGN), 2 with RPGN associated with hemorrhagic vasculitis, 1 with idiopathic RPGN, 4 with chronic glomerulonephritis (CGN), 1 with chronic pyelonephritis, and 1 with polycystic kidneys. In 11 patients with RPGN, the rate of renal failure progression, expressed by the regression coefficient, was much higher among those in whom HD treatment was discontinued that in the group of patients without renal function recovery. In the 4 patients with CGN, renal function was recovered after the correction of marked disorders of purine metabolism, whereas in the 1 patient with chronic pyelonephritis and in the 1 with polycystic kidneys after urinary infection elimination. According to the ultrasonography data, out of the 17 patients with partial recovery of renal function, the size of the kidneys turned out normal in 14 patients.